Position statements

Position statements are reviewed by the relevant Standing Advisory Committee on a regular basis or whenever significant changes are identified.

2025

January: Surveillance: preparedness for emerging infectious agents (PDF 256KB)

2024

December: Changing whole blood donation frequency in response to blood shortages (PDF 174KB)
September: COVID-19 vaccines and blood transfusion (including pre-deposit autologous and directed donations) (PDF 101KB)
September: Dengue Virus (PDF 129KB)
September: Ebola Virus (PDF 96KB)
September: Mpox Virus (PDF 133KB)
September: The estimated residual risk that a donation made in the infectious window period is not detected on testing: risks specific for HBV, HCV and HIV in the UK (2021-2023) (PDF 111KB)
September: Variant Creutzfeldt-Jakob Disease (vCJD) (PDF 241KB)
September: West Nile Virus (PDF 193KB)
May: Chikungunya Virus (PDF 58KB)
May: Guidance for the addition and removal of an infectious disease risk entry in the GDRI (PDF 89KB)
May: SARS-CoV-2/COVID-19 and the safety of substances of human origin (SoHO) (PDF 79KB)
April: Donor selection and donation management for transgender and non-binary donors (PDF 220KB)

2023

October: Human herpesvirus 8 (HHV-8) (PDF 135KB)
May: Perfluoroalkyl and polyfluoroalkyl substances (PFAS) (PDF 116KB)

2021

September: Zika Virus (PDF 119KB)
March: Granulocyte therapy (PDF 773KB)

2020

June: Blood donor selection to minimise risk of transfusion transmissible infectious agents entering the blood supply (PDF 276KB)
June: X-ray irradiation of blood components (PDF 494KB)

2017

June: Calcium abnormalities and apheresis donation (PDF 401KB)